We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Abacus Life, Inc. (ABL) Soars 6.9%: Is Further Upside Left in the Stock?
Read MoreHide Full Article
Abacus Life, Inc. (ABL - Free Report) shares soared 6.9% in the last trading session to close at $7.10. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 12.5% loss over the past four weeks.
The surge in price reflects investors' optimism on the announcement of a 90-day pause on tariffs imposed by President Trump on most countries, though a 10% tariff stays in place.
ABL stays focused on consolidating its position as a leading market maker and global alternative asset manager. The strength of partnerships with carriers and reinsurers remains a key contributor to its performance.
Marketing initiatives, international expansion, prudent capital deployment, increased assets under management and expanding institutional relationships bode well for growth. Focusing on innovative technology represents a core and growing part of its business strategy.
This company is expected to post quarterly earnings of $0.15 per share in its upcoming report, which represents a year-over-year change of +36.4%. Revenues are expected to be $35.85 million, up 66.8% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For Abacus Life, Inc., the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on ABL going forward to see if this recent jump can turn into more strength down the road.
Abacus Life, Inc. is a member of the Zacks Insurance - Life Insurance industry. One other stock in the same industry, Voya Financial (VOYA - Free Report) , finished the last trading session 11.6% higher at $60.54. VOYA has returned -19.5% over the past month.
Voya's consensus EPS estimate for the upcoming report has changed -0.8% over the past month to $1.69. Compared to the company's year-ago EPS, this represents a change of -10.1%. Voya currently boasts a Zacks Rank of #3 (Hold).
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Abacus Life, Inc. (ABL) Soars 6.9%: Is Further Upside Left in the Stock?
Abacus Life, Inc. (ABL - Free Report) shares soared 6.9% in the last trading session to close at $7.10. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 12.5% loss over the past four weeks.
The surge in price reflects investors' optimism on the announcement of a 90-day pause on tariffs imposed by President Trump on most countries, though a 10% tariff stays in place.
ABL stays focused on consolidating its position as a leading market maker and global alternative asset manager. The strength of partnerships with carriers and reinsurers remains a key contributor to its performance.
Marketing initiatives, international expansion, prudent capital deployment, increased assets under management and expanding institutional relationships bode well for growth. Focusing on innovative technology represents a core and growing part of its business strategy.
This company is expected to post quarterly earnings of $0.15 per share in its upcoming report, which represents a year-over-year change of +36.4%. Revenues are expected to be $35.85 million, up 66.8% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For Abacus Life, Inc., the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on ABL going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Abacus Life, Inc. is a member of the Zacks Insurance - Life Insurance industry. One other stock in the same industry, Voya Financial (VOYA - Free Report) , finished the last trading session 11.6% higher at $60.54. VOYA has returned -19.5% over the past month.
Voya's consensus EPS estimate for the upcoming report has changed -0.8% over the past month to $1.69. Compared to the company's year-ago EPS, this represents a change of -10.1%. Voya currently boasts a Zacks Rank of #3 (Hold).